Post-earnings recap
Reported
Thu, Aug 27, 2026
EPS actual
$1.24
EPS est.
$0.99
EPS surprise
+24.87%
1-day move
-10.56%
Despite beating EPS expectations, HealthEquity's stock fell by 10.56% following the earnings report. This decline may be attributed to investor reaction to the lack of specific revenue figures and potential concerns about broader market conditions. However, the company showed strong growth in HSA accounts and user engagement, which could bode well for future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.24 | N/A | +24.87% |
| Revenue Growth YoY | 8% | N/A | N/A |
| Adjusted EBITDA Margin | 48% | N/A | N/A |
| Total HSA Accounts | 10.7 million | N/A | N/A |
| Monthly Active Users | 1.4 million | N/A | N/A |
Management expressed optimism about the company's growth, highlighting record engagement metrics and a solid increase in HSA assets. They also noted the positive impact of marketplace activity on overall performance.
The company reported record engagement with a significant increase in monthly active users.
HealthEquity raised its fiscal 2027 revenue guidance, reflecting strong performance.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
HealthEquity, Inc. is a healthcare technology company that provides solutions for managing health savings accounts and other health-related financial services. With a market cap of $9 billion, it plays a crucial role in the managed healthcare sector, especially as consumers increasingly seek ways to manage healthcare costs and savings.
Last quarter
In the last quarter, HealthEquity reported an EPS of $1.24, significantly beating estimates by 31.63%. The stock reacted positively, gaining 4.57% the next day.
Management promises and guidance
EPS beat streak
6Q
EPS beat rate
88%
Avg EPS surprise
+32.04%
Avg 1-day reaction
-0.40%
Investors are generally optimistic about HealthEquity's upcoming earnings, especially given its strong track record of beating EPS estimates. However, the lack of revenue guidance may create uncertainty.
Bull case
If HealthEquity continues its trend of beating EPS estimates, it could see significant stock appreciation as investors gain confidence in its growth potential.
Bear case
Conversely, if the company fails to provide clear guidance or shows signs of slowing growth, it could lead to a negative reaction in the stock price.
Key metrics to watch
Earnings Per Share (EPS)
Expected to be around $1.24.EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.
Revenue Growth
Not available.Revenue growth reflects the company's ability to expand its services and attract more customers, which is vital for long-term success.
The print will turn on these.
Q1
What will be the EPS for this quarter?
Given the company's strong history of EPS surprises, this number will be critical in determining market sentiment.
Q2
What is the outlook for customer growth in the next quarter?
Customer growth is essential for sustaining revenue and profitability, and any guidance on this will be closely watched.
Why consensus could be wrong
The Street may be underestimating HealthEquity's ability to continue its growth trajectory, especially in customer acquisition.
Supporting evidence
HealthEquity has consistently beaten EPS estimates, indicating strong operational execution.
The options market is pricing a larger move than historical averages, suggesting that traders expect significant volatility.
The company's commitment to enhancing technology platforms may drive customer growth more than anticipated.
Key risk
If customer growth exceeds expectations, it could significantly alter the market's perception of HealthEquity's future.
Pre-commit to what would confirm each case.
The market is debating whether HealthEquity can maintain its growth trajectory amid increasing competition and economic pressures.
Bull confirmed if
An EPS of $1.30 or higher would confirm strong operational performance and growth.
Bear confirmed if
An EPS below $1.10 would signal potential issues with profitability and growth.
What the market is pricing for the move.
Implied Move
±12.47%
Historical Avg
±2.4%
The options market is pricing in a significant move, suggesting that traders anticipate volatility around the earnings announcement.
Options are pricing ±12.5% while HQY has averaged ±2.4% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
38.7%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If HealthEquity beats expectations, history suggests the stock could rise by around 0.75%, confirming strong operational performance.
In line / cautious
If results are in line with expectations but lack strong guidance, the stock may experience a muted reaction as investors reassess growth prospects.
Miss
If the company misses EPS expectations, history suggests a potential decline of about 0.94%, raising concerns about future performance.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
3
3 buys·0 sells
Members
1
House only
Est. Notional
$3,003.00–$45,000.00
disclosed dollar ranges
Most Active Members
3 trades
The lines on the call that would change the story.
Customer Growth Rate
Not available.An increase in customers indicates the company's market acceptance and effectiveness in attracting new clients.
Net buying
Recent Transactions
Traded Jul 10, 2026 · disclosed Sep 4, 2026
$1,001.00–$15,000.00
Traded Jun 30, 2026 · disclosed Jul 2, 2026
$1,001.00–$15,000.00
Traded May 29, 2026 · disclosed Jun 8, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.